Title |
Adult antiretroviral therapy guidelines 2017
|
---|---|
Published in |
Southern African Journal of HIV Medicine, July 2017
|
DOI | 10.4102/sajhivmed.v18i1.776 |
Pubmed ID | |
Authors |
Graeme Meintjes, Michelle A Moorhouse, Sergio Carmona, Natasha Davies, Sipho Dlamini, Cloete van Vuuren, Thandekile Manzini, Moeketsi Mathe, Yunus Moosa, Jennifer Nash, Jeremy Nel, Yoliswa Pakade, Joana Woods, Gert Van Zyl, Francesca Conradie, Francois Venter |
Abstract |
These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in 2015. Since the release of the previous guidelines, the scale-up of antiretroviral therapy (ART) in southern Africa has continued. New antiretroviral drugs have become available with improved efficacy, safety and robustness. The guidelines are intended for countries in the southern African region, which vary between lower and middle income. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
South Africa | 13 | 76% |
United States | 1 | 6% |
Ethiopia | 1 | 6% |
Unknown | 2 | 12% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 15 | 88% |
Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 263 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 53 | 20% |
Researcher | 26 | 10% |
Student > Ph. D. Student | 26 | 10% |
Student > Postgraduate | 24 | 9% |
Student > Bachelor | 21 | 8% |
Other | 43 | 16% |
Unknown | 70 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 81 | 31% |
Nursing and Health Professions | 24 | 9% |
Biochemistry, Genetics and Molecular Biology | 12 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 4% |
Agricultural and Biological Sciences | 9 | 3% |
Other | 37 | 14% |
Unknown | 89 | 34% |